Reviewed by Michael Gill, B. Sc.
25 Hereditary Angioedema Clinical Trials Near Me
Top Hospitals for Hereditary Angioedema Clinical Trials
Image of Optimed Research, LTD in Ohio.
Optimed Research, LTD
Columbus
4Active Trials
10All Time Trials for Hereditary Angioedema
2009First Hereditary Angioedema Trial
Image of Washington University School of Medicine in Missouri.
Washington University School of Medicine
Saint Louis
4Active Trials
10All Time Trials for Hereditary Angioedema
2010First Hereditary Angioedema Trial
Most Recent Hereditary Angioedema Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Top Treatments for Hereditary Angioedema Clinical Trials
Treatment Name
Active Hereditary Angioedema Clinical Trials
All Time Trials for Hereditary Angioedema
First Recorded Hereditary Angioedema Trial
KVD900 600 mg
3
3
2022
Donidalorsen
2
4
2020
Eplontersen
2
2
2020
Bevacizumab
2
2
2010
Chatbot
1
1
2022
Recently Completed Studies with FDA Approved Treatments for Hereditary Angioedema
Treatment
Year
Sponsor
CSL312
2021
CSL Behring
Lanadelumab
2020
Shire

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: November 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Beard N, Frese M, Smertina E, Mere P, Katelaris C, Mills K. Interventions for the long-term prevention of hereditary angioedema attacks. Cochrane Database Syst Rev. 2022 Nov 3;11:CD013403. doi: 10.1002/14651858.CD013403.pub2. Review. https://pubmed.ncbi.nlm.nih.gov/363264352 Davis JL. The Blunt End: Surgical Challenges of Gene Therapy for Inherited Retinal Diseases. Am J Ophthalmol. 2018 Dec;196:xxv-xxix. doi: 10.1016/j.ajo.2018.08.038. Epub 2018 Sep 5. https://pubmed.ncbi.nlm.nih.gov/301949313 Davis JL. The Blunt End: Surgical Challenges of Gene Therapy for Inherited Retinal Diseases. Am J Ophthalmol. 2018 Dec;196:xxv-xxix. doi: 10.1016/j.ajo.2018.08.038. Epub 2018 Sep 5. Review. https://pubmed.ncbi.nlm.nih.gov/301949314 Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000 Mar 6;91(1):66-7. https://pubmed.ncbi.nlm.nih.gov/107510925 Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000 Mar 6;91(1):66-7. doi: 10.1002/(sici)1096-8628(20000306)91:13.0.co;2-p. https://pubmed.ncbi.nlm.nih.gov/107510926 Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010 Apr;120(4):838-43. doi: 10.1002/lary.20818. Erratum in: Laryngoscope. 2021 Oct 28;:. https://pubmed.ncbi.nlm.nih.gov/200879697 Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010 Apr;120(4):838-43. doi: 10.1002/lary.20818. Erratum In: Laryngoscope. 2021 Dec;131(12):2834. https://pubmed.ncbi.nlm.nih.gov/200879698 Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010 Apr;120(4):838-43. doi: 10.1002/lary.20818. Erratum in: Laryngoscope. 2021 Dec;131(12):2834. https://pubmed.ncbi.nlm.nih.gov/200879699 Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010 Apr;120(4):838-43. doi: 10.1002/lary.20818. https://pubmed.ncbi.nlm.nih.gov/2008796910 Feuer WJ, Schiffman JC, Davis JL, Porciatti V, Gonzalez P, Koilkonda RD, Yuan H, Lalwani A, Lam BL, Guy J. Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results. Ophthalmology. 2016 Mar;123(3):558-70. doi: 10.1016/j.ophtha.2015.10.025. Epub 2015 Nov 19. https://pubmed.ncbi.nlm.nih.gov/26606867